Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ACADEMIA
ACADEMIA
- 7 Japan Scientific Societies Issue Proposal on Development of Vaccines, Anti-Infectives
August 3, 2022
- Deregulation Likely to Create 1.15 Trillion Yen Headroom for Switched OTC Growth: Health Economist
July 15, 2022
- Gynecologist Cautious about Inclusion of Pregnant Women in Clinical Trials, but Says ICH Move Will Spark Safety Discussions
July 14, 2022
- NCC Doctor Hails MHLW’s Policy on Use of Clinical Research Data in Regulatory Filing
June 22, 2022
- Kitasato University Spinoff PRD to Develop Lipid Metabolism Control Agents
June 10, 2022
- NCGM, IQVIA Pair Up to Unravel “Long COVID” by Building Large-Scale Registry
May 31, 2022
- A Dozen Regional Formularies to Be Launched by Year-End, Pharmacists Must Take the Lead: Society Chief
May 25, 2022
- Difficult-to-Quantify Factors Should Be Reflected in Drug Prices to Establish VBP: Health Economist
May 9, 2022
- 5 Academic Societies Prod Price Rethink for 32 Key Antibiotics to Stabilize Supply
May 9, 2022
- Insurance Coverage of Fertility Treatments Could Reduce Patients’ Payments by 20-30%: Obstetrician
April 11, 2022
- Ex-JAMS President Fumimaro Takaku Dies at 91
March 28, 2022
- Exon 44-Targeted DMD Drug Hits Goals in PI/II: NCNP/Nippon Shinyaku
March 18, 2022
- Japan Researchers Test Efficacy of COVID Drugs for BA.2 Omicron Subvariant
March 11, 2022
- Infectious Diseases Society Issues Updated COVID-19 Guide
February 21, 2022
- COVID-19 Vaccines for Ages 5 to 11 Meaningful: Japan Pediatric Society
January 20, 2022
- Oita University Completes Dosing of Replicon RNA Vaccine in PI, Eyes Global PII/III
January 19, 2022
- Kyoto Univ., Takeda Succeed in Treating Muscular Dystrophy in Model Mice Using Genome Editing
December 10, 2021
- With First Ophthalmologic Biosimilar Set to Debut, Specialist Says Close Attention Required for Unexpected Side Effects
December 9, 2021
- Swift Actions to Improve Diagnostic System, Control Costs Required to Prep for Potential Aducanumab Debut: JSDR Confab
November 30, 2021
- Anti-CGRP Antibodies Cut Headaches in 70% of Patients, but Cost Will Be Major Obstacle: Specialist
October 21, 2021
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…